CID 137964141

2-methyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1-{[2-(trimethylsilyl)ethoxy]methyl}-1h-imidazole; acetic acid

Structural Information

Molecular Formula
C16H31BN2O3Si
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=CN(C(=N2)C)COCC[Si](C)(C)C
InChI
InChI=1S/C16H31BN2O3Si/c1-13-18-14(17-21-15(2,3)16(4,5)22-17)11-19(13)12-20-9-10-23(6,7)8/h11H,9-10,12H2,1-8H3
InChIKey
RTWDAGJFMGNDAD-UHFFFAOYSA-N
Compound name
trimethyl-[2-[[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazol-1-yl]methoxy]ethyl]silane
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

338.2197 Da
Monoisotopic Mass

None
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 339.22698 174.5
[M+Na]+ 361.20892 183.9
[M+NH4]+ 356.25352 182.8
[M+K]+ 377.18286 180.3
[M-H]- 337.21242 177.1
[M+Na-2H]- 359.19437 179.1
[M]+ 338.21915 176.9
[M]- 338.22025 176.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.